Journal article
Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions
Abstract
AIM: The aim of the present study was to analyse concomitant drug use and its association with outcome in patients (N = 17 701) receiving rivaroxaban or standard of care (SOC) for the prevention of venous thromboembolism after major orthopaedic surgery in the non-interventional, phase IV XAMOS (Xarelto® in the prophylaxis of post-surgical venous thromboembolism after elective major orthopaedic surgery of hip or knee) study.
METHODS: Concomitant …
Authors
Kreutz R; Haas S; Holberg G; Lassen MR; Mantovani LG; Schmidt A; Turpie AGG
Journal
British Journal of Clinical Pharmacology, Vol. 81, No. 4, pp. 724–734
Publisher
Wiley
Publication Date
April 2016
DOI
10.1111/bcp.12836
ISSN
0306-5251